FDA proposes standardizing testing of talc-containing products for asbestos - Down to Business
An OB/GYN was terse in her feedback, saying she needed an answer to inquiries from patients on whether their ovarian cancer ...
Downside risk from talc lawsuit, Stelara generic competition is 'manageable': JNJ CFO Joe Wolk
Johnson & Johnson's (JNJ) stock fell more than 3% Wednesday morning, trading at $143 per share despite a beat in earnings for ...